V.ii.3.D.3.e. Procedure for Referring Claims for Extra-Schedular Consideration | | Follow the steps in the table below when referring claims for extra-schedular consideration under either 38 CFR 3.321(b)(1) or 38 CFR 4.16(b). | Step | Action |
|---|
| 1 | Complete the appropriate memorandum as shown in M21-1, Part V, Subpart ii, 3.D.3.g or h. Note: When referring a claim to Compensation Service for consideration of both38 CFR 3.321(b)(1) or 38 CFR 4.16(b), the request may be submitted under the same memo as long as the memo fully discusses both extra-schedular provisions and provides recommendations for both. | | 2 | Obtain the required signatures on VA Form 21-0961, Rating Decision/Administrative Decision/Formal Finding/Statement of the Case (SOC)/Supplemental Statement of the Case (SSOC) (Electronic Signatures). | | 3 | Upload the memorandum and all other relevant documents to the Veteran’s electronic claims folder. | | 4 | Use the table below to refer the claim to Compensation Service for extra-schedular consideration. | If the claim is … | Then … |
|---|
| processed in the National Work Queue (NWQ) environment | assign the Compensation Service Review – Extraschedular special issue indicator to the relevant contention(s), and Compensation Service Case Review tracked item in accordance with the NWQ Phase 1 &2 Playbook to ensure proper routing to Compensation Service. | | not processed in the NWQ environment | - assign the
- Compensation Service Review – Extraschedular special issue indicator to the relevant contention(s), and
- Compensation Service Case Review tracked item, and
- manually broker the end product (EP) to Compensation Service (Washington DC).
Reference: For more information on manually brokering EPs, see the VBMS Core User Guide. | Reference: For more information on assigning special issue indicators and tracked items, see |
V.ii.3.D.3.g. Exhibit 1: 38 CFR 3.321(b)(1) Referral Memorandum | | This exhibit contains a sample of the memorandum completed for 38 CFR 3.321(b)(1) referrals. DEPARTMENT OF VETERANS AFFAIRS[RO Name RO Address][Date] Director In Rely Refer To:Compensation Service (214D) [RO #]Department of Veterans Affairs [File Number]Central Office [Veteran’s Name]810 Vermont Ave. NWWashington, DC 20420 SUBJECT: Administrative Review for Entitlement to Increased Evaluation in Accordance with 38 CFR § 3.321(b)(1)BACKGROUND INFORMATION: [List service information, such as branch, dates, and place(s) of service.]STATEMENT OF ISSUE: [State specific review requested, including any relevant time period and whether the issue is part of a Board of Veterans’ Appeals (BVA) remand.]Example: Review for entitlement to an increased evaluation on an extra-schedular basis for bilateral hearing loss. EVIDENCE: [List the evidence used for this review.]Example:- Rating decision dated August 1, 2008
- BVA decision/remand dated November 1, 2015
- VA examinations dated June 7, 2008, July 10, 2010, September 12, 2015, and June 20, 2016
DISCUSSION: [Discuss medical evidence in detail for each SC disability related to the request for all pertinent time periods, to include medical evidence found within the file and the BVA remand.]Example: Service connection has been established for bilateral hearing loss. This condition has been evaluated at zero percent disabling since January 6, 2008. The Veteran is requesting an increased evaluation for this condition. BVA remanded this issue on November 1, 2015, and directed that the case be referred for consideration of entitlement to an increased evaluation on an extra-schedular basis from January 6, 2008, to present. VA examinations dated June 7, 2008, July 10, 2010, and September 12, 2015, document that the Veteran’s hearing loss has been appropriately evaluated at zero percent disabling for the time period of this review. Speech recognition scores were 96% for the right ear and 94% for the left ear. On June 20, 2016, another examination was performed. Testing revealed a slight deterioration in the bilateral hearing loss; however this change is not sufficient to warrant an increased evaluation on a schedular basis. Speech recognition scores remained at previous levels. The examiner stated that the Veteran’s hearing loss would not preclude employment. The examiner further stated that the Veteran would have some difficulty working in situations with a lot of background noise.Evidence shows that the Veteran attended college for two years and worked as an engineer following separation from service. He retired from this position in January of 2012, after 23 years. Evidence does not show that the bilateral hearing loss interfered with employment. Extra-schedular evaluations are assigned in cases where an exceptional or unusual disability picture is presented with such related factors as marked interference with employment or frequent periods of hospitalization that renders application of regular rating schedular standards impractical. No unusual or exceptional disability pattern has been demonstrated that would render application of the regular rating criteria as impractical. The evidentiary record does not demonstrate that the symptomatology consistently associated with the service-connected bilateral hearing loss supports an increased evaluation on a schedular or extra-schedular basis for any time period.RECOMMENDATION:[Provide a recommendation, to include an effective date, if applicable.]Example: Deny an increased evaluation on an extra-schedular basis for bilateral hearing loss.SIGNATURES: [Document signatures on VA Form 21-0961 by following procedures in M21-1, Part X, Subpart v, 1.C.3.e.] |
|
V.ii.3.D.3.h. Exhibit 2: 38 CFR 4.16(b) Referral Memorandum | | This exhibit contains a sample of the memorandum completed for 38 CFR 4.16(b) referrals. DEPARTMENT OF VETERANS AFFAIRS[RO NameRO Address] [Date] Director In Rely Refer To:Compensation Service (214D) [RO #]Department of Veterans Affairs [File Number]Central Office [Veteran’s Name] 810 Vermont Ave. NWWashington, DC 20420 SUBJECT: Administrative Review for Entitlement to Total Disability Rating Based on Individual Unemployability (TDIU) in Accordance with 38 CFR 4.16(b)BACKGROUND INFORMATION: [List service information, such as branch, dates, and place(s) of service.] STATEMENT OF ISSUE: [State specific review requested, including any relevant time period and whether the issue is part of a BVA remand.]Example: Review for entitlement to TDIU benefits on an extra-schedular basis for the period June 20, 2016, to May 1, 2017. EVIDENCE: [List the evidence used for this review]Example:- Rating decision dated April 15, 2016
- BVA remand dated June 1, 2017
- VA Form 21-8940, Veteran's Application for Increased Compensation Based on Unemployability, received January 12, 2016
- Transcript of hearing, dated May 19, 2017
- VA examinations dated December 2012, March 2014, and May 2016
- Social Security Administration (SSA) disability transmittal sheet, dated January 30, 2016
DISCUSSION: [Discuss medical evidence in detail for each SC disability related to the request for all pertinent time periods, to include medical evidence found within the file and the BVA remand.]Example: Service connection has been established for three conditions. Posttraumatic stress disorder (PTSD) was evaluated at 30 percent disabling effective January 2, 2013, and increased to 50 percent disabling effective January 3, 2016; arthritis of the right knee has been evaluated at 10 percent disabling since June 5, 2010, and bilateral hearing loss has been evaluated at zero percent disabling since June 5, 2010. The combined evaluation for compensation was 10 percent effective June 5, 2010; 40 percent effective January 2, 2013, and 60 percent effective January 3, 2016. BVA remanded this issue on January 1, 2017, and directed that the case be referred for entitlement to IU benefits on an extra-schedular basis from January 2, 2013, to present date. Evidence from SSA shows that the Veteran was found to be entitled to SSA disability benefits in June of 2013. The primary condition utilized to make that decision was disorders of the spine, and the secondary condition was disorders of the knee. Evidence shows that the Veteran attended college for four years and worked as an automobile salesperson following separation from service. He retired from this position in January of 2012, after 26 years. Evidence does not show that the service-connected conditions interfered with employment. VA psychiatric examinations performed in December of 2012, March of 2014, and May of 2016, demonstrate that the Veteran’s PTSD has deteriorated since 2013. The Veteran has never been hospitalized for PTSD, and records show no therapy sessions prior to January of 2016. The Veteran took prescription medication prescribed by his family doctor until December of 2015, when he first started treatment with a psychiatrist. Evidence shows no hallucinations, delusions, or suicidal or homicidal ideations at any time. The Veteran’s depression and anxiety (symptoms of PTSD) increased in severity in late 2015. He started having occasional panic attacks and having difficulty getting along with family members and friends. He started to isolate himself more often and had difficulty sleeping most nights. Evidence does not include any medical opinions indicating that the PTSD interfered with prior employment or would prevent employment at any time. A VA musculoskeletal examination performed in March of 2014, revealed full motion of the right knee with pain. X-ray evidence revealed arthritis. No instability of the knee was found. The Veteran reported pain with extended periods of walking and standing. He takes over-the-counter pain medication as needed for knee pain. He does not use a cane or other ambulatory aids. No surgery has been performed on the right knee. A VA examination performed in March of 2014 revealed a mild bilateral hearing loss. The Veteran was able to hear well during the examination. His speech discrimination scores were 98% in each ear. The examiner stated that the hearing loss would not affect employment. It is the established policy of the Department of Veterans Affairs that all Veterans who are unable to secure and follow a substantially gainful occupation by reason of service-connected disabilities shall be rated totally disabled. None of the available evidence supports the Veteran’s contention that any of his service-connected disabilities or a combination of the effects of the disabilities prevents all types of gainful activity. RECOMMENDATION:[Provide a recommendation, to include an effective date, if applicable.]Example: Grant entitlement to TDIU on an extra-schedular basis effective June 20, 2017.SIGNATURES: [Document signatures on VA Form 21-0961 by following procedures in M21-1, Part X, Subpart v, 1.C.3.e.] |
|
4. P&T EvaluationsIntroduction | | This topic contains information on the rating determination for DEA under 38 U.S.C. Chapter 35, including- definition of a
- total disability, and
- permanent disability
- requirement for permanence
- evidentiary threshold for establishing permanence
- establishing permanence for chronic, progressive disabilities
- date of P&T disability
- when claimed or raised as a subordinate issue, and
- upon cancellation or dismissal of review examination control
- P&T reasons for decision
- addressing the P&T status of disabilities normally requiring a review examination, and
- granting P&T without Dependents' Educational Assistant (DEA).
|
V.ii.3.D.4.a. Definition: Total Disability | | Total disability means- schedular or extraschedular evaluations of 100 percent under, or by analogy to, any DC in 38 CFR Part 4
- a combined evaluation of 100 percent, or
- a total evaluation on the basis of IU.
Reference: For more information on a total disability evaluation for the loss of paired organs or extremities under 38 U.S.C. 1160, see Kimberlin v. Brown, 5 Vet.App. 174 (1993). |
V.ii.3.D.4.b. Definition: Permanent Disability | | Permanent disability means disabling manifestations reasonably certain to continue throughout the lifetime of the individual. Reference: For more information on permanent disability, see |
V.ii.3.D.4.c. Requirement for Permanence | | The mere existence of a total disability evaluation is not sufficient to establish a P&T evaluation. The evidence must establish permanence of the total evaluation, as discussed in M21-1, Part V, Subpart ii, 3.D.4.d. Total evaluations assigned under the following provisions are temporary: - prestabilization (38 CFR 4.28)
- extended VA hospitalization (38 CFR 4.29)
- convalescence (38 CFR 4.30), and
- any DC that provides for a limited period of total disability for convalescence such as joint replacements or cardiac procedures.
Exceptions: - Veterans who are considered P&T disabled prior to the assignment of a 100-percent evaluation under a DC with a limited duration and future examination will be considered permanently disabled during the total evaluation. The status of permanency is reconsidered following completion of the examination. Example: A Veteran who is considered permanently and totally disabled because of a heart disorder based on metabolic equivalents (METs) undergoes cardiac transplantation surgery. The Veteran would continue to be considered P&T disabled for the duration of the one-year convalescent period under 38 CFR 4.104, DC 7019.
- A temporary total evaluation on the date of death will establish a P&T disability. Total disability did persist from the date assigned until the end of the person’s life.
|
V.ii.3.D.4.d. Evidentiary Threshold for Establishing Permanence | | Permanence of a total disability evaluation may be established when the evidence of record clearly establishes that a disability is expected to continue at its current level of severity. However, clear and specific evidence is not required to establish permanence. When the evidence of record does not clearly or specifically show that the total disability will continue but alsodoes not show that a reexamination to ascertain improvement is warranted pursuant to 38 CFR 3.327(b)(2), concede permanence of the evaluation based on a reasonable certainty that improvement is not likely. The following fact patterns demonstrate scenarios in which P&T disability is established based on the preponderance of the evidence of record.- Evidence at the time of evaluation affirmatively shows that the total disability will continue for the remainder of the person’s life.
- Evidence at the time of evaluation does not specifically support that the total disability will continue for the remainder of the person’s life but does not show that the condition is likely to improve pursuant to 38 CFR 3.327(b)(2). In such cases, a future examination control is inappropriate so the total disability rating is static; in the absence of re-evaluation, total disability is likely to continue for the remainder of the person’s life.
- At or before the time of maturation of a future examination diary pertinent to the continuation of total disability, the future examination control is canceled because
- Total disability has been in effect for 20 or more years per 38 CFR 3.951. In such cases, the total disability is protected and is therefore static and will continue for the remainder of the person’s life.
- A qualifying individual with total disability dies. In such cases, the total disability is permanent because it persisted until the end of the person’s life.
Notes: - The evidentiary threshold provided in 38 U.S.C. 3501(a)(8) to establish permanence is that there must be a reasonable certainty that the level of impairment will continue throughout the life of the disabled person. This threshold means that there is more than an approximate balance of evidence indicating that the level of impairment will continue indefinitely.
- For historical purposes, a 100-percent evaluation under the 1925 rating schedule also meets the criteria of a “total disability, permanent in nature,” for DEA, per 38 CFR 3.952.
Reference: For more information on the definition of static disability, see M21-1, Part IV, Subpart ii, 2.B.2.b. |
V.ii.3.D.4.e. Establishing Permanence for Chronic, Progressive Disabilities | | When evidence indicates that cancer or other similarly chronic and progressive disabilities are not expected to improve, concede permanence for the disability evaluation. Examples of indicators suggesting the likelihood that the disability status is permanent include but are not limited to- a prescription for palliative treatment only for a cancer diagnosis
- a prescription for hospice care, or
- an indicator in medical evidence that the condition is considered terminal.
|
V.ii.3.D.4.f. Date of P&T Disability When Claimed or Raised as a Subordinate Issue | | Basic eligibility based on a P&T SC disability is only established when all criteria (i.e., SC, total disability, and permanence of disability) are met. Therefore, the date of P&T disability is the later of - the date of claim, or
- the date that the final criterion is factually established.
Notes: - If medical evidence reviewed in connection with a claim portrays an increase in SC disability, warranting a finding of permanence, establish the P&T evaluation and apply the effective date provisions of whichever of the following is more applicable/appropriate:
- When results of a VA-initiated review/future examination portray permanence of an individual or combined total disability evaluation, establish basic eligibility to a P&T evaluation as of the date the examination was performed.
- Attribute examination or other findings dated after the date of claim back to the date of claim unless there is specific evidence there was a change to total disability or to permanece of disability between the date of claim and the date of the evidence.
Example: A VA examination finding that contains an opinion on permanence of disability would be attributed to the date of claim unless there was specific evidence dated on or after the date of claim, and prior to the VA examination date, indicating that the total disability was likely to improve, in which case the date of permanence would be the date of examination. References: For more information on |
V.ii.3.D.4.g. Date of P&T Disability Upon Cancellation or Dismissal of Review Examination Control | | Use the table below to determine the date of P&T disability when- there is total disability but no indication of permanence based on an established future or review examination control, and
- a P&T determination is subsequently necessitated by one of the following actions:
- cancellation of the future examination control prior to maturation, or
- determination that a review examination should not be scheduled at the time the future examination control matures.
| When the action is based on ... | Then ... |
|---|
| a determination that the examination control was initially set up in errorExample: In violation of 38 CFR 3.327(b)(2), a future examination control is set for a condition, like amytrophic lateral sclerosis (ALS), that can only be rated at 100 percent and is, by its nature, permanent. | set the date of P&T disability as if the future examination control were never established. Explanation: The examination control was erroneous; therefore, the condition was static at the time of the rating decision establishing SC. | | a difference in judgment rather than a specific error in the initial future examination control Example: The rating activity determines, prior to scheduling, that a review examination should not be scheduled as planned because the conclusion of likely future improvement used to set the future examination control was not well justified by the facts. | use the date of reviewfor the date of P&T disability. Explanation: This is essentially a new determination of permanency on the date of review caused by reexamination of the facts. | | new evidence that changes the prior assessment that the total disability is likely to improve, as indicated by a future examination control | use the date that the new evidence is received for the date of P&T disability. Exception: When the new evidence portraying disability permanence is dated within one year prior to the date of the current review, apply the effective date provisions of 38 CFR 3.400(o)(2). References: For more information on effective dates |
|
V.ii.3.D.4.h. P&T Reasons for Decision | | Rating decisions establishing P&T status must provide - the basis for the decision, and
- a discussion of the evidence supporting the decision.
|
V.ii.3.D.4.i. Addressing the P&T Status of Malignancies | | VBMS-R’s system-generated language for evaluating totally disabling SC malignancies or other disabilities normally requiring a review examination usually includes reference to the scheduling of a mandatory review examination intended to determine recurrence or residual disability. When, however, P&T status of the SC disability has been conceded in light of the guidance in M21-1, Part V, Subpart ii, 3.D.4.e, edit the rating decision narrative by replacing the system-generated text displayed in the left column of the table below with the text displayed in the right column.| VBMS-R System-Generated Text | Replacement Text |
|---|
| A rating of 100 percent shall continue beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of 38 CFR §3.105(e). If there has been no local recurrence or metastasis, you will be rated on residuals. | The medical evidence shows that permanence of this disability has been established. Consequently, no future VA examination will be requested. | References: For more information on |
5. Principles of Disability Evaluation for Specific Conditions
Introduction | | This topic contains information about evaluating specific conditions or circumstances, including- evaluating malignant neoplasms and associated impairments
- examples of evaluating diagnosed disabilities due to malignant neoplasms
- evaluating an SC disability eliminated by NSC amputation, and
- considering recurrent or refractory symptoms.
|
Change Date | | September 15, 2021 |
V.ii.3.D.5.a. Evaluating Malignant Neoplasms and Associated Impairments | | Use the table below to determine whether a symptom or condition associated with an active malignant neoplasm may be separately evaluated during the period in which a 100-percent evaluation is warranted for the active malignant neoplasm. | If the condition is a ... | Then ... |
|---|
| purely symptomatic complaint arising from the malignant neoplasm | do not assign a separate evaluation. | | symptom arising from treatment for the malignant neoplasm | do not assign a separate evaluation. | | diagnosed disability deemed to be caused by or related to the malignant neoplasm | - apply 38 CFR 4.14 to determine whether the symptoms of the diagnosed disability are considered in the 100-percent evaluation for the malignant neoplasm
- review the evaluation criteria for both conditions and other applicable provisions to determine whether separate evaluations are allowable, and
- if the pyramiding rule in 38 CFR 4.14 has not been violated and separate evaluations are otherwise allowable, assign a separate evaluation.
Note: When the DC for the active malignancy is directive as to how to evaluate residuals of the cancer, conditions or symptoms that- would be rated as residuals should not be assigned a separate evaluation during the pendency of the 100-percent evaluation for the active malignancy, and
- would not be rated as residuals may be granted separately and concurrently with the 100-percent evaluation.
| | metastatic malignant neoplasm affecting a different body system than is affected by the primary SC neoplasm | assign a separate evaluation. Note: For the purpose of determining entitlement to SMC at the statutory housebound rate under 38 CFR 3.350(i)(1), carcinoma that has metastasized and involves two different body systems would generally be considered separate and distinct. The fact that there is an etiological relationship does not preclude considering the impact and effects as separate and distinct. | | metastatic malignant neoplasm affecting the same body system as is affected by the primary SC neoplasm | do not assign a separate evaluation. Note: This guidance is applicable when language within a particular DC refers to malignant neoplasms in plural. | Note: If doubt arises as to the medical cause or association of any symptoms or diagnosis, a medical opinion should be requested for clarification. References: For more information on- assignment of separate evaluations for individual findings, see M21-1, Part V, Subpart ii, 3.D.2.b, and
- entitlement to SMC based on housebound status, see M21-1, Part VIII, Subpart iv, 4.A.10.
|
V.ii.3.D.5.b. Examples of Evaluating Diagnosed Disabilities Due to Malignant Neoplasms | | Example 1: SC for anxiety disorder claimed and diagnosed as secondary to active lung cancer may be granted and separately evaluated. Example 2: A Veteran is SC with a 100-percent evaluation assigned for active renal cancer and undergoes a nephrectomy as a part of the treatment for the renal cancer. 38 CFR 4.115b, DC 7528 directs that renal cancer is evaluated as active malignancy and its residuals are evaluated based on either voiding dysfunction or renal dysfunction. Since a nephrectomy is evaluated either with the minimum compensable evaluation or as renal dysfunction under 38 CFR 4.115b, DC 7500, the rating schedule recognizes that renal dysfunction is within the predominant symptomatology of both disabilities. Since both criteria contemplate renal dysfunction, the nephrectomy cannot be separately evaluated. Example 3: A Veteran is SC with a 100-percent evaluation assigned for active renal cancer. The Veteran is diagnosed with recurrent pyelonephritis which is characterized by symptoms of recurrent urinary tract infection. The pyelonephritis is identified as a complication of the renal cancer. 38 CFR 4.115b, DC 7528 directs that renal cancer is evaluated as active malignancy and its residuals are evaluated based on either voiding dysfunction or renal dysfunction. Since the pyelonephritis is characterized by recurrent urinary tract infection, which is not considered within the criteria for evaluating malignant neoplasms of the genitourinary system, a separate evaluation may be assigned under 38 CFR 4.115b, DC 7504 utilizing the urinary tract infection symptoms. Example 4: A Veteran is SC with a 100-percent evaluation assigned under 38 CFR 4.114, DC 7343 for active colon cancer. The Veteran sustained a nerve injury during surgery for the colon cancer resulting in impairment of anal sphincter control with incontinence. Since the symptoms of impairment of sphincter control with incontinence are due to a separately diagnosed disability (the nerve injury), pyramiding rules are not violated, and 38 CFR 4.114 does not prohibit separate evaluations for these coexisting digestive system disabilities, a separate evaluation may be assigned for the nerve injury with impairment of sphincter control under 38 CFR 4.114, DC 7332. Example 5: A Veteran is SC with a 100-percent evaluation assigned under 38 CFR 4.115b, DC 7528. A VA examination revealed a diagnosis of erectile dysfunction due to the prostate cancer. Since 38 CFR 4.115b, DC 7528 directs that prostate cancer is evaluated based on residuals consisting of voiding dysfunction or urinary tract infection, SC for the erectile dysfunction should be established concurrently with the 100-percent evaluation. |
V.ii.3.D.5.c. Evaluating an SC Disability Eliminated by NSC Amputation | | Where an NSC cause necessitates amputation of an extremity resulting in elimination of an SC disability distal to the site of the amputation, do not sever SC for or reduce the evaluation of the SC disability. |
V.ii.3.D.5.d. Considering Recurrent or Refractory Symptoms | | Many evaluation criteria require consideration of the frequency of occurrence of symptoms. Two descriptions used throughout the rating schedule for frequency of occurrence are refractory and recurrent. - Recurrent describes signs, symptoms, or a disease that returns after a period of remission (or a period of time during which the symptoms could not be detected).
- Refractory describes a disease, condition, or symptoms that do not respond or are resistant to treatment.
Example: The evaluation criteria for human immunodeficiency virus (HIV)-related illness at 38 CFR 4.88b, DC 6351 utilizes recurrent symptoms for the 30-percent evaluation and refractory symptoms for the 60-percent evaluation. |
Source: VA M21-1 Adjudication Procedures Manual, M21-1, Part V, Subpart ii, Chapter 3, Section D (U.S. government work, reproduced for reference). Browse all sections →
|